ADVM - Adverum Biotechnologies, Inc.

QQQ $ 619.89 $ 0.00 (0 %)

DIA $ 481.81 $ 0.00 (0 %)

SPY $ 681.95 $ 0.00 (0 %)

TLT $ 89.86 $ 0.00 (0 %)

GLD $ 389.60 $ 0.00 (0 %)

Previous Close

$ 4.3

Open

$ 4.30

Bid

$ 4.24 x 300

Ask

$ 4.30 x 20

Day's Range

-- - --

52 Week Range

$ 1.78 - $ 8.05

Volume

255,719

Average Volume

Market Cap

94.93M

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-12-2025	09-30-2025	10-Q
2	08-12-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	04-15-2025	12-31-2024	10-K
5	11-04-2024	09-30-2024	10-Q
6	08-12-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	03-18-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-30-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-29-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	03-01-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-28-2020	03-31-2020	10-Q
24	03-12-2020	12-31-2019	10-K
25	11-07-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	03-06-2019	12-31-2018	10-K
29	11-08-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-09-2018	03-31-2018	10-Q
32	03-06-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-08-2017	06-30-2017	10-Q
35	05-09-2017	03-31-2017	10-Q
36	03-09-2017	12-31-2016	10-K
37	11-08-2016	09-30-2016	10-Q
38	08-09-2016	06-30-2016	10-Q
39	05-06-2016	03-31-2016	10-Q
40	03-04-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

eli-lilly-bets-big-on-eye-gene-therapy-that-could-end-repeat-injections

Eli Lilly Bets Big On Eye Gene Therapy Tha...
10/24/2025 15:14:59

Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future milestones.

Lilly To Acquire Adverum Biotechnologies F...
10/24/2025 12:34:14

Trading Halt: Halted at 8:25:00 a.m. ET - ...
10/24/2025 12:25:04

HC Wainwright & Co. Reiterates Buy on Adve...
09/23/2025 10:53:59

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

12 Health Care Stocks Moving In Monday's I...
09/22/2025 17:06:11

Adverum Biotechnologies Says Screening For...
09/22/2025 12:09:57

Chardan Capital Maintains Buy on Adverum B...
08/13/2025 14:26:04

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $33 price t...

Adverum Biotechnologies Q2 EPS $(2.34) Mis...
08/12/2025 11:09:44

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(2.34) per share which missed the analyst consensus estimat...

Mizuho Maintains Outperform on Adverum Bio...
06/26/2025 14:59:15

Mizuho analyst Graig Suvannavejh maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Outperform and lowers the price targ...

RBC Capital Maintains Sector Perform on Ad...
05/15/2025 15:55:51

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price tar...

Chardan Capital Maintains Buy on Adverum B...
05/15/2025 15:33:24

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $33 price t...

HC Wainwright & Co. Reiterates Buy on Adve...
05/15/2025 11:01:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

Adverum Biotechnologies Q1 EPS $(2.25) Mis...
05/14/2025 21:43:22

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(2.25) per share which missed the analyst consensus estimat...

intuit-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday

Intuit To Rally Around 19%? Here Are 10 To...
04/17/2025 12:49:11

Chardan Capital Maintains Buy on Adverum B...
04/17/2025 11:38:22

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and lowers the price targ...

RBC Capital Maintains Sector Perform on Ad...
04/16/2025 15:19:04

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price tar...

HC Wainwright & Co. Reiterates Buy on Adve...
04/16/2025 11:01:24

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

Adverum Biotechnologies Q4 EPS $(1.96) Mis...
04/15/2025 11:43:33

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimat...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/09/2025 12:07:29

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
03/31/2025 21:05:46